Wound Care (Pharmacies) - Bahrain

Bahrain

Highlights

Revenue in the Wound Care market is projected to reach US$410.70k in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.06%, resulting in a market volume of US$411.80k by 2029.
In global comparison, most revenue will be generated United States (US$1.04bn in 2024).
In relation to total population figures, per person revenues of US$0.27 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Wound Care (Pharmacies) market in Bahrain is experiencing steady growth due to changing customer preferences and the increasing prevalence of chronic wounds. Customer preferences in the Wound Care (Pharmacies) market in Bahrain are shifting towards products that promote faster healing and provide better pain relief. Customers are increasingly seeking advanced wound care products that use innovative technologies such as hydrogel dressings, foam dressings, and negative pressure wound therapy. These products are preferred as they offer better wound management and reduce the risk of infection. Additionally, customers are also looking for wound care products that are easy to use and require minimal maintenance, allowing them to manage their wounds at home without the need for frequent visits to healthcare facilities. One of the key trends in the Wound Care (Pharmacies) market in Bahrain is the increasing prevalence of chronic wounds. Chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, are becoming more common due to factors such as an aging population, sedentary lifestyles, and the high prevalence of diabetes and obesity. This trend is driving the demand for wound care products that can effectively treat chronic wounds and promote faster healing. Another trend in the market is the growing adoption of advanced wound care technologies. Advanced wound care products, such as bioactive dressings, growth factors, and skin substitutes, are gaining popularity due to their ability to accelerate the healing process and improve patient outcomes. These products are increasingly being used in healthcare facilities and are also becoming more accessible to patients through pharmacies. The adoption of advanced wound care technologies is expected to further drive the growth of the Wound Care (Pharmacies) market in Bahrain. In addition to customer preferences and market trends, there are also local special circumstances that are influencing the development of the Wound Care (Pharmacies) market in Bahrain. The country has a well-established healthcare system with a high standard of care, which includes wound care services. This has led to a strong demand for wound care products in pharmacies, as patients prefer to manage their wounds at home with the support of healthcare professionals. Furthermore, Bahrain has a growing elderly population, which is more susceptible to chronic wounds. This demographic factor is also contributing to the growth of the Wound Care (Pharmacies) market in Bahrain. Underlying macroeconomic factors, such as the overall economic growth and healthcare expenditure in Bahrain, are also driving the development of the Wound Care (Pharmacies) market. The country has a strong economy and a high level of healthcare spending, which allows for investment in advanced wound care technologies and the availability of a wide range of wound care products in pharmacies. The government's focus on healthcare infrastructure development and the provision of quality healthcare services also contribute to the growth of the market. Overall, the Wound Care (Pharmacies) market in Bahrain is developing due to changing customer preferences, the increasing prevalence of chronic wounds, the adoption of advanced wound care technologies, local special circumstances, and underlying macroeconomic factors. With the continued focus on innovation and the provision of quality wound care products, the market is expected to further expand in the coming years.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.